Aadi Bioscience Announces Poster Presentations at 2023 AACR-

Two new real-world next-generation sequencing studies reinforce prevalence of TSC1/2 mutations in up to 2% of all tumors, a significant addressable cancer population
PRECISION1 tumor-agnostic trial...

Related Keywords

Boston , Massachusetts , United States , Brian Mcmorran , Marcy Graham , Shihe Hou , Andrew Kwon , Maria Zalath , Gopa Iyer , Sean Wallace , Khine Nyein Myint , Normaa Palma , Igor Vivanco , Willish Navarro , Aadi Bioscience , Foundation Medicine , Twitter , Prnewswire Aadi Bioscience Inc , Company Annual Report On Form , Linkedin , Nasdaq , International Conference On Molecular , Aadi Bioscience Inc , Molecular Targets , Cancer Therapeutics , Poster Session , Open Label Basket Trial , Looking Statements , Private Securities Litigation Reform Act , Annual Report , Quarterly Reports , Markets ,